Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
Chinmay Dwibedi, Ola Ekström, J. Leonard Brandt, et al.
Nature Metabolism (2024) Vol. 6, Iss. 1, pp. 50-60
Open Access | Times Cited: 12

Showing 12 citing articles:

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 34
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Comparative Cardiovascular and Renal Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Systematic Review
H. Khan, Zarbakhta Ashfaq, J. Hamza, et al.
Cureus (2025)
Open Access
Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes
Hao Wu, Bo‐Min Lv, Luqian Zhi, et al.
Nature Medicine (2025)
Open Access
Hétérogénéité du diabète de type 2 : avancées vers la médecine de précision
Tran Bao Vuong, Jean‐Baptiste Julla, Nicolas Venteclef, et al.
Médecine des Maladies Métaboliques (2025)
Open Access
Semaglutide effects on safety and cardiovascular outcomes in patients with overweight or obesity: a systematic review and meta-analysis
André Saad Cleto, João Matheus Schirlo, Mayara Beltrame, et al.
International Journal of Obesity (2024)
Closed Access | Times Cited: 2
Therapeutic potential of isoniazid carbohydrazide derivatives as a promising anti-inflammatory and anti-diabetic drug via synthesis, characterization, biological screening, and computational studies
Krishnakumar Ranganathan, Meenakshi Srinivasan, Maqusood Ahamed, et al.
Journal of Molecular Structure (2024), pp. 141106-141106
Closed Access | Times Cited: 1
A second step towards precision medicine in diabetes
Xiantong Zou, Linong Ji
Nature Metabolism (2024) Vol. 6, Iss. 1, pp. 10-11
Closed Access
Insulinsekretion und Insulinclearance in verschiedenen Diabetessubtypen
Oana‐Patricia Zaharia
Deleted Journal (2024) Vol. 20, Iss. 5, pp. 617-621
Closed Access
Risiken diabetesassoziierter Komorbiditäten in Subgruppen des Typ-2-Diabetes
Oana‐Patricia Zaharia, Nikolaus Marx, Malte Kelm, et al.
Aktuelle Kardiologie (2024) Vol. 13, Iss. 04, pp. 257-262
Closed Access
Precision medicine in diabetes care
Si Hua Clara Tan, Wann Jia Loh, Su Chi Lim
Current Opinion in Endocrinology Diabetes and Obesity (2024)
Closed Access
pH-Responsive EGCG-Metal self-assembly as the carrier for rapid and prolonged insulin delivery
Shuifang Mao, Yanming Ren, Yujun Zeng, et al.
Chemical Engineering Journal (2024), pp. 159048-159048
Closed Access
Page 1

Scroll to top